These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1270 related items for PubMed ID: 17122799

  • 1. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.
    Gotto AM, Farmer JA.
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):664-72. PubMed ID: 17122799
    [Abstract] [Full Text] [Related]

  • 2. Statin and ezetimibe combination therapy in cardiovascular disease.
    Dembowski E, Davidson MH.
    Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):183-8. PubMed ID: 19262375
    [Abstract] [Full Text] [Related]

  • 3. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
    Daskalopoulou SS, Mikhailidis DP.
    Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035
    [Abstract] [Full Text] [Related]

  • 4. Rationale for targeting multiple lipid pathways for optimal cardiovascular risk reduction.
    Ballantyne CM.
    Am J Cardiol; 2005 Nov 07; 96(9A):14K-19K; discussion 34K-35K. PubMed ID: 16291009
    [Abstract] [Full Text] [Related]

  • 5. Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin.
    Gazi IF, Daskalopoulou SS, Nair DR, Mikhailidis DP.
    Curr Med Res Opin; 2007 Sep 07; 23(9):2183-92. PubMed ID: 17692154
    [Abstract] [Full Text] [Related]

  • 6. Role of ezetimibe in the prevention of cardiovascular disease: absence of evidence.
    Mascitelli L, Pezzetta F, Goldstein MR.
    Arch Med Res; 2010 Nov 07; 41(8):649-50. PubMed ID: 21199735
    [Abstract] [Full Text] [Related]

  • 7. Is there a problem with ezetimibe or just ENHANCEd hype?
    Whayne TF.
    Angiology; 2010 Nov 07; 59(6):661-3. PubMed ID: 18796445
    [No Abstract] [Full Text] [Related]

  • 8. Clinical significance of recent lipid trials on reducing risk in patients with type 2 diabetes mellitus.
    Jones PH.
    Am J Cardiol; 2007 Feb 19; 99(4A):133B-140B. PubMed ID: 17307065
    [Abstract] [Full Text] [Related]

  • 9. Clinical use of ezetimibe.
    Cheng AY, Leiter LA.
    Can J Clin Pharmacol; 2003 Feb 19; 10 Suppl A():21A-5A. PubMed ID: 14571302
    [Abstract] [Full Text] [Related]

  • 10. [Dual inhibition of cholesterol using the drug combination ezetimibe/simvastatin?].
    Vaverková H.
    Vnitr Lek; 2007 Apr 19; 53(4):421-7. PubMed ID: 17578178
    [Abstract] [Full Text] [Related]

  • 11. The efficacy and safety of ezetimibe for treatment of dyslipidemia after heart transplantation.
    Crespo-Leiro MG, Paniagua MJ, Marzoa R, Grille Z, Naya C, Flores X, Rodriguez JA, Mosquera V, Franco R, Castro-Beiras A.
    Transplant Proc; 2008 Nov 19; 40(9):3060-2. PubMed ID: 19010194
    [Abstract] [Full Text] [Related]

  • 12. [Therapy of dyslipidemia in post-infarction: state of the art].
    Borgia MC, Nardi M, Da Ros S, Castellano V.
    Clin Ter; 2007 Nov 19; 158(6):523-32. PubMed ID: 18265719
    [Abstract] [Full Text] [Related]

  • 13. Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction.
    Robinson JG, Davidson MH.
    Expert Rev Cardiovasc Ther; 2006 Jul 19; 4(4):461-76. PubMed ID: 16918265
    [Abstract] [Full Text] [Related]

  • 14. Ezetimibe as a potential treatment for dyslipidemia associated with chronic renal failure and renal transplant.
    Ahmed MH, Khalil AA.
    Saudi J Kidney Dis Transpl; 2010 Nov 19; 21(6):1021-9. PubMed ID: 21060168
    [Abstract] [Full Text] [Related]

  • 15. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
    Hou R, Goldberg AC.
    Endocrinol Metab Clin North Am; 2009 Mar 19; 38(1):79-97. PubMed ID: 19217513
    [Abstract] [Full Text] [Related]

  • 16. The ezetimibe controversy: implications for clinical practice.
    Khanderia U, Regal RE, Rubenfire M, Boyden T.
    Ther Adv Cardiovasc Dis; 2011 Aug 19; 5(4):199-208. PubMed ID: 21636623
    [Abstract] [Full Text] [Related]

  • 17. [LDL cholesterol in cardiovascular risk patients should be as low as possible].
    MMW Fortschr Med; 2007 Oct 11; 149(41):44-5. PubMed ID: 17992793
    [No Abstract] [Full Text] [Related]

  • 18. Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy.
    Pearson TA, Ballantyne CM, Veltri E, Shah A, Bird S, Lin J, Rosenberg E, Tershakovec AM.
    Am J Cardiol; 2009 Feb 01; 103(3):369-74. PubMed ID: 19166691
    [Abstract] [Full Text] [Related]

  • 19. Ezetimibe: cholesterol lowering and beyond.
    Bays HE, Neff D, Tomassini JE, Tershakovec AM.
    Expert Rev Cardiovasc Ther; 2008 Apr 01; 6(4):447-70. PubMed ID: 18402536
    [Abstract] [Full Text] [Related]

  • 20. Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic disease.
    Teoh H, Mendelsohn AA, Goodman SG, Jaffer S, Chen RY, Tjia S, Theriault L, Langer A, Leiter LA, Guidelines Based Undertaking for Improvement in Dyslipidemia Related Events (GUIDE) Investigators.
    Am J Cardiol; 2009 Sep 15; 104(6):798-804. PubMed ID: 19733714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 64.